BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16458301)

  • 1. Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
    Kocken CH; van der Wel A; Arbe-Barnes S; Brun R; Matile H; Scheurer C; Wittlin S; Thomas AW
    Exp Parasitol; 2006 Jul; 113(3):197-200. PubMed ID: 16458301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.
    Hofer S; Brun R; Maerki S; Matile H; Scheurer C; Wittlin S
    J Antimicrob Chemother; 2008 Nov; 62(5):1061-4. PubMed ID: 18669520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
    Snyder C; Chollet J; Santo-Tomas J; Scheurer C; Wittlin S
    Exp Parasitol; 2007 Mar; 115(3):296-300. PubMed ID: 17087929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of P. falciparum populations from Colombia and Tanzania to a new synthetic peroxide (OZ277).
    Osorio L; Murillo C; Aponte S; Mayagaya V; Scheurer C; Brun R; Matile H; Wittlin S
    Am J Trop Med Hyg; 2007 Jun; 76(6):1024-6. PubMed ID: 17556605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from Gabon.
    Kreidenweiss A; Mordmüller B; Krishna S; Kremsner PG
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1535-7. PubMed ID: 16569877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
    Maerki S; Brun R; Charman SA; Dorn A; Matile H; Wittlin S
    J Antimicrob Chemother; 2006 Jul; 58(1):52-8. PubMed ID: 16735432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
    Dong Y; Wittlin S; Sriraghavan K; Chollet J; Charman SA; Charman WN; Scheurer C; Urwyler H; Santo Tomas J; Snyder C; Creek DJ; Morizzi J; Koltun M; Matile H; Wang X; Padmanilayam M; Tang Y; Dorn A; Brun R; Vennerstrom JL
    J Med Chem; 2010 Jan; 53(1):481-91. PubMed ID: 19924861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium vivax: in vitro antiparasitic effect of cyclosporins.
    Kocken CH; van der Wel A; Rosenwirth B; Thomas AW
    Exp Parasitol; 1996 Dec; 84(3):439-43. PubMed ID: 8948333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
    Kaiser M; Wittlin S; Nehrbass-Stuedli A; Dong Y; Wang X; Hemphill A; Matile H; Brun R; Vennerstrom JL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2991-3. PubMed ID: 17562801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
    Chotivanich K; Udomsangpetch R; Chierakul W; Newton PN; Ruangveerayuth R; Pukrittayakamee S; Looareesuwan S; White NJ
    Am J Trop Med Hyg; 2004 Apr; 70(4):395-7. PubMed ID: 15100453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interaction of artemisinin derivatives or the fully synthetic peroxidic anti-malarial OZ277 with thapsigargin in Plasmodium falciparum strains.
    Abiodun OO; Brun R; Wittlin S
    Malar J; 2013 Jan; 12():43. PubMed ID: 23368889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid immunochromatography-based detection of mixed-species malaria infection in Pakistan.
    Beg MA; Ali SS; Haqqee R; Khan MA; Qasim Z; Hussain R; Smego RA
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):562-4. PubMed ID: 16124417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
    Guthmann JP; Pittet A; Lesage A; Imwong M; Lindegardh N; Min Lwin M; Zaw T; Annerberg A; de Radiguès X; Nosten F
    Trop Med Int Health; 2008 Jan; 13(1):91-8. PubMed ID: 18291007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
    Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
    Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
    Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes.
    Nacher M; Silachamroon U; Singhasivanon P; Wilairatana P; Phumratanaprapin W; Fontanet A; Looareesuwan S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2751-2. PubMed ID: 15215143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
    Lee KS; Kim TH; Kim ES; Lim HS; Yeom JS; Jun G; Park JW
    Am J Trop Med Hyg; 2009 Feb; 80(2):215-7. PubMed ID: 19190216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.